TEXAS DEPARTMENT OF STATE HEALTH SERVICES Infectious Disease Prevention Section Epi Case Criteria Guide, 2021 Revision date: March 2021 Texas Department of State Health Services Epi Case Criteria Guide, 2021 Editors Katherine Bourne Thomas Tanabe, MPH, MBA Contributors Adam Lynch, MPH Elise Huebner, MS, CPH, CIC Kelly Broussard, MPH Adrienne Fung, MPH Ekaete Okon, MPH, RS Kenneth Davis, MPH Amira Bashadi, MPH Gillian Blackwell, BSN, RN, CIC Laura Robinson, DVM, MS Atisha Morrison, MPH, REHS Inger-Marie Vilcins, PhD, MPH Melissa Freeland, MPH Bobbiejean Garcia, MPH, CIC, FAPIC Irina Cody, MPH Rachael Singer, PhD, MSPH Bonny Mayes, MA Johnathan Ledbetter, MPH Rachael Straver, DVM, MPH Briana O’Sullivan, MPH Julie Bassett, MPH, CPH Rania Milleron, PhD, MS Carlos R. Alvarez, MPH, CPH, A-IPC Kamesha Owens, MPH Sandi Arnold, RN, CIC Celeste Zamarron, BS Eric Garza, MPH Texas Department of State Health Services Infectious Disease Prevention Section Emerging and Acute Infectious Disease Branch//Zoonosis Control Branch Mail Code 1960 PO Box 149347 Austin, TX 78714-9347 Phone 512.776.7676 • Fax 512.776.7616 Revised: February 2021 Publication No. E59-11841 Revision date: March 2021 ~ ii ~ REVISIONS MADE FROM THE 2020 TO THE 2021 EPI CASE CRITERIA GUIDE Revisions of case criteria for Clinical Description and/or criteria (CD); Confirmed, Probable, Possible, or Suspect cases (CC, PC, PsC, SC); Laboratory Confirmation tests (LC); and Note(s) (N) ▪ Acute Flaccid Myelitis .................................................... CD, PC, SC, LC, N ▪ Novel Coronavirus 2019.......................................................................CD, N ▪ Ascariasis ............................................................................................ CD, LC ▪ Prion diseases such as Creutzfeldt-Jakob disease ....... CD, CC, PC, PsC, N ▪ Babesiosis ............................................................................ CD, CC, PC, LC ▪ Q Fever, Acute ........................................................................................... LC ▪ Botulism, foodborne .......................................................................... CD, LC ▪ Q Fever, Chronic ........................................................................................ LC ▪ Botulism, infant .................................................................................. CD, LC ▪ Rickettsia ......................................................................... Classification Notes ▪ Botulism, other or unspecified .................................................................. CD ▪ Salmonella Paratyphi ................................................................ CD, CC, LC ▪ Botulism, wound ................................................................................ CD, LC ▪ Salmonella Typhi ............................................................... CD, CC, PC, LC ▪ Campylobacteriosis ....................................................................... CD, CC, N ▪ Salmonella, non-Paratyphi/non-Typhi................................................. CC, N ▪ Cholera ........................................................................................................ CD ▪ Shiga toxin-producing Escherchia coli (STEC) .................. PC, SC, LC, N ▪ Cryptosporidiosis ....................................................................................... LC ▪ Shigellosis .................................................................................................. CC ▪ Cyclosporiasis .................................................................................... CD, LC ▪ Smallpox ............................................................................................... LC, N ▪ Ebola (HF) .................................................................................................. LC ▪ Spotted fever rickettsiosis ............................................................ CD, LC, N ▪ Fascioliasis ................................................................................................. CD ▪ Trichuriasis ................................................................................................ CD ▪ Hemolytic uremic syndrome, post-diarrheal (HUS) .................................. N ▪ Tularemia ................................................................................................... PC ▪ Hepatitis E, acute ....................................................................................... CD ▪ Vibrio parahaemolyticus .................................................................. CD, CC ▪ Hookworm ......................................................................................... CD, LC ▪ Vibrio vulnificus ......................................................................................... CC ▪ Influenza, human isolates [outbreaks only] ................................................. N ▪ Vibriosis, other or unspecified .......................................................... CD, CC ▪ Leishmaniasis ............................................................................................ CD ▪ Yersiniosis ......................................................................................... CD, CC ▪ Listeriosis ................................................................................................... LC ▪ Zika infection, congenital ........................................................................... N ▪ Lyme Disease ............................................................................................. LC ▪ Zika infection, non-congenital .................................................................... N ▪ Norovirus [outbreaks only] ....................................................................... CD Added Notifiable Conditions ▪ Candida auris (C. auris) ▪ Relapsing Fever, Tick-borne (TBRF) Removed Notifiable Conditions ▪ Amebiasis ▪ Group A Streptococcus, invasive (GAS) ▪ Group B Streptococcus, invasive (GBS) All these disease conditions were removed on January 5, 2021 ▪ Multidrug-resistant Acinetobacter (MDR-A) Revision date: March 2021 ~ iii ~ TABLE OF CONTENTS This document provides infectious disease information for surveillance and data entry staff. It contains a table with condition codes, condition names, and case criteria to aid in the classification and coding of conditions. It is organized alphabetically by condition name. Conditions specified as reportable in Title 25, Texas Administrative Code, Chapter 97, Subchapter A, Control of Communicable Diseases are in bold type. Click on a condition in the table of contents to go to the text and on the condition code to move back. Editors ............................................................................................................................................................................................................................................ ii Contributors ................................................................................................................................................................................................................................. ii REVISIONS MADE FROM THE 2020 TO THE 2021 EPI CASE CRITERIA GUIDE ....................................................... iii Table of Contents ........................................................................................................................................................................... iv Definition of Terms .......................................................................................................................................................................vii Abbreviations ............................................................................................................................................................................... viii Notes ................................................................................................................................................................................................ ix CASE CRITERIA ............................................................................................................................................................................... 10 Acute Flaccid Myelitis ..................................................................................................................................................................................................................................................................................... 10 Amebic meningitis/encephalitis, other................................................................................................................................................................................................................................................ 11 Am Amebic meningoencephalitis, primary (PAM) ............................................................................................................................................................................................................................. 12 Anaplasmosis (Anaplasma phagocytophilum infection) ........................................................................................................................................................................................................ 12 Anthrax .................................................................................................................................................................................................................................................................................................................